comparemela.com

Latest Breaking News On - Louise modis - Page 2 : comparemela.com

Mogrify appoints Tom Graney as Non-Executive Director, Audit Chair and Capital Markets Advisor

Mogrify Limited (Mogrify), a biopharmaceutical company pioneering the development of a new class of in vivo reprogramming therapies and transforming the development of ex vivo cell therapies, today announced

New yorkUnited statesLorenz mayrTom graneyKostenloser wertpapierhandelMichelle rickettsLouise modisDarrinm disleyVertex pharmaceuticalsInternational businessMogrify limitedZyme communicationsIronwood pharmaceuticalsUniversity of delawareNon executive directorAudit chair

Chutes & Ladders—Pfizer s development leader is retiring in early 2022

Pfizer's chief development officer, Rod MacKenzie, is the Big Pharma's second executive to retire in early 2022. NIH Director Francis Collins will also hit the exit, before the end of this year. Sanofi poaches Gilead cancer executive Valeria Fantin to run its oncology research.

New yorkUnited statesKarin bultmanGarth kinbergerCamille mcmullenRobert ashworthThomas farleyMary margaret huizingaJeffrey humphreyBeth llewellynDavid graingerMorgan molloyFresenius kabiDavid ballDenny kimMike weinstein

Mogrify Limited: Mogrify Strengthens Executive Leadership Team with the Appointment of Louise Modis as Chief Scientific Officer

Mogrify Limited (Mogrify), a biopharmaceutical company pioneering the development of a new class of in vivo reprogramming therapies and transforming the development of ex vivo cell therapies, today announced

United statesBaden wübergHarvard universityKostenloser wertpapierhandelMichelle rickettsLouise modisDarrinm disleyBoehringer ingelheim pharmaceuticalsMillennium pharmaceuticalsMogrify executive teamImmunology networkMogrify limitedNational university of irelandImmunology research at glaxosmithklineZyme communicationsChief scientific officer

vimarsana © 2020. All Rights Reserved.